Is Ivosidenib Tablets Possible to Cure Myeloid Leukemia Patients?

Avonib is an oral small molecule targeted drug, mainly targeting patients with acute myeloid leukemia (AML) with mutations in the IDH1 (isocitrate dehydrogenase 1) gene. IDH1Mutation can lead to abnormal cell metabolism, promote cancer cell proliferation and hinder normal cell differentiation. Ivonib selectively inhibits the activity of mutant IDH1 enzyme and restores the normal differentiation process of cells, thereby inhibiting the growth of leukemia cells.

In clinical trials, ivosidenib has shown significant efficacy, especially in patients with IDH1mutations who are intolerant to conventional chemotherapyAML, the response rate has been significantly improved, and some patients have achieved complete remission (CR) or even complete molecular remission (CRm). However, ivonib is primarily used as maintenance or remission therapy, and there is currently insufficient evidence that it alone can cure all patients with myeloid leukemia.

AMLIt is a highly heterogeneous malignant tumor, and it is difficult to eradicate all cancer cells with a single target treatment. Although ivonib is effective against specific molecular targets, leukemia cells may evade treatment through other pathways. In addition, the presence of leukemia stem cells and the complexity of genetic mutations also increase the difficulty of complete cure. Therefore, ivonib is regarded more as an important means to prolong patient survival and improve quality of life.

Avosidenib is usually used in combination with other treatments, such as chemotherapy, hematopoietic stem cell transplantation (HSCT), etc., in order to achieve better therapeutic effects. In the future, with the advancement of more clinical studies and the development of new combination regimens, ivonib may play a greater role in improving the cure rate of AML patients. Patients should scientifically formulate treatment plans under the guidance of professional doctors, combined with individual genetic conditions and overall treatment plans.

Reference materials:https://www.drugs.com